Stay updated on GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial
Sign up to get notified when there's something new on the GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial page.

Latest updates to the GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check9 days agoChange DetectedMajor change: update to v3.2.0 and a prominent notice about government funding impact and operating status; remove the old v3.1.0 reference.SummaryDifference2%
- Check16 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedPatch-level update: bump Revision from v3.0.1 to v3.0.2 and remove the Back to Top element. No substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has undergone significant updates, including the addition of numerous location details across various countries, while also removing outdated location entries and some medical conditions. The facility name and specific conditions related to glecaprevir and pibrentasvir have been added, indicating a focus on updated medical information.SummaryDifference7%
- Check59 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial page.